DiaMedica Therapeutics (DMAC) EBIT (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported EBIT of -$10.5 million for Q1 2026, down 28.71% on a YoY basis from -$14.7 million in Q1 2025, and down 13.77% quarter-over-quarter from -$9.2 million in Q4 2025.
DiaMedica Therapeutics (DMAC) EBIT (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported EBIT for 9 years, with the latest figure at -$10.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 28.71% year-over-year to -$10.5 million; the trailing twelve-month figure through Mar 2026 stood at -$36.7 million (down 505.69% YoY), and the FY2025 full-year result was -$34.4 million, down 839.3% from the prior year.
- EBIT for Q1 2026 stood at -$10.5 million, down from -$9.2 million in the prior quarter.
- The five-year high for EBIT was $14.6 million in Q4 2024, with the low at -$10.5 million in Q1 2026.
- Historically, EBIT has averaged -$4.9 million across 5 years, with a median of -$5.6 million in 2024.
- Annual changes were most pronounced in 2024 — EBIT soared 349.66% — and 2025, when it slumped 163.1%.
- DiaMedica Therapeutics' EBIT stood at -$4.0 million in 2022, then sank by 47.19% to -$5.8 million in 2023, then soared by 349.66% to $14.6 million in 2024, then tumbled by 163.1% to -$9.2 million in 2025, then dropped by 13.77% to -$10.5 million in 2026.
- The last three EBIT figures came in at -$10.5 million (Q1 2026), -$9.2 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -10.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.48 Mn |
| Dec 31, 2025 | -9.21 Mn |
| Sep 30, 2025 | -9.03 Mn |
| Jun 30, 2025 | -8.01 Mn |
| Mar 31, 2025 | -8.14 Mn |
| Dec 31, 2024 | 14.60 Mn |
| Sep 30, 2024 | -6.88 Mn |
| Jun 30, 2024 | -5.64 Mn |
| Mar 31, 2024 | -5.74 Mn |
| Dec 31, 2023 | -5.85 Mn |
| Sep 30, 2023 | -5.16 Mn |
| Jun 30, 2023 | -4.74 Mn |
| Mar 31, 2023 | -5.52 Mn |
| Dec 31, 2022 | -3.97 Mn |
| Sep 30, 2022 | -3.13 Mn |
| Jun 30, 2022 | -3.36 Mn |
| Mar 31, 2022 | -3.54 Mn |
| Dec 31, 2021 | -3.25 Mn |
| Sep 30, 2021 | -3.42 Mn |
| Jun 30, 2021 | -3.37 Mn |